Archangels-backed company files first patent on platform targeting one of oncology’s fastest-growing therapy classes.
Scotland’s Bead BioPharma, a Scottish life sciences company backed by Archangels, announced its emergence from stealth mode following the submission of its first patent, a milestone that marks the company’s formal entry into one of the most commercially active sectors in global oncology.
Read more HERE.
